Urenco Isotopes provides the world with stable and medical isotopes for medical, research and industry uses.
Visit our Isotopes websiteSee what actions we are taking to achieve net zero by 2040 in our net zero transition plan.
Read it hereOur increased order book and solid financial and operational performance provide basis for future growth.
Read our latest report03 October 2016
On 15 September 2016, Urenco CEO, Thomas Haeberle, presented at the WNA’s annual symposium held at Park Plaza Westminster Bridge, London.
More than 600 leaders and specialists in nuclear energy from over 35 countries were expected to attend the industry event which took place from 14-16 September.
In his first WNA presentation, which was well received, Thomas Haeberle provided an update on Urenco including our strengths, our operational achievements and our financial performance.
He then shared his thoughts on the global enrichment market and how it’s best to respond to the changing market before concluding with his thoughts on what the enrichment business of the future will look like.
About Urenco
Urenco is an international supplier of enrichment services and fuel cycle products with sustainability at the core of its business. Operating in a pivotal area of the nuclear fuel supply chain for 50 years, Urenco facilitates zero carbon electricity generation for consumers around the world.
With its head office near London, UK, Urenco’s global presence ensures diversity and security of supply for customers through enrichment facilities in Germany, the Netherlands, the UK and the USA. Using centrifuge technology designed and developed by Urenco, and through the expertise of our people, the Urenco Group provides safe, cost effective and reliable services; operating within a framework of high environmental, social and governance standards, complementing international safeguards.
Urenco is committed to continued investment in the responsible management of nuclear materials; innovation activities with clear sustainability benefits, such as nuclear medicine, industrial efficiency and research; and nurturing the next generation of scientists and engineers.
Media enquiries